Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2000
08/17/2000WO2000047725A1 Nitroreductase enzymes
08/17/2000WO2000047716A2 Fibres for culturing eukaryotic cells
08/17/2000WO2000047623A1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
08/17/2000WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
08/17/2000WO2000047615A2 Proteins related to neuronal regeneration and uses thereof
08/17/2000WO2000047607A1 A synthetic peptide disturbing intracellular signaling
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047601A1 Shortened-chain polynucleotides and process for the preparation thereof
08/17/2000WO2000047599A1 Novel nucleosides and oligonucleotide analogues
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047581A1 Therapeutic nucleoside compound
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047577A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047574A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047571A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation
08/17/2000WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/17/2000WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047561A1 Non-nucleoside reverse transcriptase inhibitors
08/17/2000WO2000047559A2 5-ht1f agonists
08/17/2000WO2000047558A1 Amide compounds and medicinal use thereof
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047551A2 Inhibitors of aspartyl protease
08/17/2000WO2000047234A1 Sustained release salts of pharmaceutically active peptides and their production
08/17/2000WO2000047217A2 Protection of cells in connection with treatment with chemical agents
08/17/2000WO2000047206A1 Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation
08/17/2000WO2000047200A1 Combinations of formoterol and a tiotropium salt
08/17/2000WO2000047199A1 Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases
08/17/2000WO2000047197A2 Alkylating agents for treatment of cellular proliferation
08/17/2000WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000026199A3 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO2000015773A3 Inhibition of oncogene transcription by synthetic polyamides
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000DE19906108A1 Schutz von Zellen im Zusammenhang mit einer Behandlung mit chemischen Agenzien Protecting cells in connection with a treatment with chemical agents
08/17/2000DE19905768A1 Pre-emulsion for hair color production contains fatty alcohol ethoxylate, oleic acid, ethanediol and/or propanediol distearate and glycerol stearate and/or sugar fatty acid ester
08/17/2000DE19904650A1 cDNA-Sequenz eines Interaktors FANCIP1 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequence of an interactor FANCIP1 of the Fanconi anemia complementation group A protein
08/17/2000CA2367575A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000CA2362883A1 Alkylating agents for treatment of cellular proliferation
08/17/2000CA2362523A1 Nitroreductase enzymes
08/17/2000CA2362464A1 A synthetic peptide disturbing intracellular signaling
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362389A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation
08/17/2000CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2361919A1 Lactam inhibitors of fxa and method
08/17/2000CA2361428A1 Inhibitors of factor xa
08/17/2000CA2361334A1 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2361034A1 Proteins related to neuronal regeneration and uses thereof
08/17/2000CA2360164A1 5-ht1f agonists
08/17/2000CA2359926A1 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000CA2359785A1 .beta.-secretase enzyme compositions and methods
08/17/2000CA2359674A1 Chain-shortened polynucleotide and method for preparation thereof
08/16/2000EP1028117A2 Novel protein: prenyl transferase inhibitors
08/16/2000EP1028114A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027892A2 Azithromycin combination for emesis control in dogs
08/16/2000EP1027891A2 Neuropeptide y antagonists
08/16/2000EP1027834A1 Food composition comprising L-arginine
08/16/2000EP1027443A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/16/2000EP1027431A2 April- a novel protein with growth effects
08/16/2000EP1027430A1 64 human secreted proteins
08/16/2000EP1027370A2 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
08/16/2000EP1027354A1 Phthalocyanine analogs
08/16/2000EP1027351A1 Phenanthroline derivatives
08/16/2000EP1027342A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
08/16/2000EP1027340A1 4, 5-diaryloxazole compounds
08/16/2000EP1027338A2 New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists
08/16/2000EP1027337A1 Integrin receptor antagonists
08/16/2000EP1027333A1 Thrombin inhibitors
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027328A1 Substituted anilides
08/16/2000EP1027075A1 Gene therapy for stimulation of angiogenesis
08/16/2000EP1027069A1 Compositions and methods for treating lysosomal storage disease
08/16/2000EP1027066A1 Soluble mhc complexes and methods of use thereof
08/16/2000EP1027065A1 Method for destroying retinal pigment epithelial cells
08/16/2000EP1027062A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
08/16/2000EP1027059A2 Enhancement of morphogen activity
08/16/2000EP1027057A1 Treatment of female sexual dysfunction
08/16/2000EP1027056A1 Alpha-ketoamide multicatalytic protease inhibitors
08/16/2000EP1027048A2 Selective cyclooxygenase-2 inhibitors against premature labor
08/16/2000EP1027046A1 Antagonists of gonadotropin releasing hormone
08/16/2000EP1027045A1 Methods and compositions for regulation of 5-alpha reductase activity
08/16/2000EP1027043A1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
08/16/2000EP1027042A1 Inhibitors of farnesyl protein transferase
08/16/2000EP1027040A2 Methods for modulating macrophage proliferation using polyamine analogs
08/16/2000EP1027036A2 Taste masked formulations
08/16/2000EP1027027A2 Therapeutic method
08/16/2000EP0934325A4 Tetraphosphonate bicyclic trisanhydrides
08/16/2000EP0923379A4 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution
08/16/2000EP0805802B1 Substituted phenyl compounds as endothelin antagonists
08/16/2000EP0799193B1 High purity n-(4-[n,n-bis(2-iodoethyl)amino]phenoscycarbonyl)-l-glutamic acid
08/16/2000EP0753015B1 Monoclonal antibodies recognizing tie-receptor and their use
1 ... 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 ... 1564